ArticleJournal of neuro-oncology2019

Baseline multicentric tumors, distant recurrences and leptomeningeal dissemination predict poor survival in patients with recurrent glioblastomas receiving bevacizumab.

Cheng Hong Toh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.